Govt Job for Pharmacists in ECHS

The ECHS Central Organisation is located at Delhi and functions under the Chief of Staff Committee (COSC) through AG and DGDC&W in Army HQ. The Central organisation is headed by Managing Director, ECHS, a serving Major General.

There are 28 Regional Centres ECHS and 426 ECHS Polyclinics. ECHS is also an attached office of Dept of Ex-Servivemen Welfare (DoESW), Ministry of Defence (MoD) as are Directorate General Resettlement(DGR) and Kendriya Sainik Board (KSB).

Ex-Servicemen Contributory Health Scheme (ECHS) invites applications to engage the following vacancies on contractual basis in Ex-Servicemen Contributory Health Scheme Polyclinic, Devlali and Ex-Servicemen Contributory Health Scheme Polyclinic, Dhule for a period of one year.

Post : Pharmacist

No of Post :03 (Devlali-02, Dhule-01)
Age Limit : For Emp-53, For Contractual-55

Basic qualification :
(i) B.Pharmacy from recognized Institute OR
(ii) (10+2) with science stream from Recognized board
(iii) Approved Diploma in Pharmacy from Recongnized by the Pharmacy Council of India and Registered as Pharmacist under the Pharmacy Act 1948

Work Exp : Minimum 3 Year experience
Desirable Attributes : Any diploma / Course in specialist Pharmacy
Salary : Rs 28,100/-

Last date of receipt of application is 18 Mar 2021.

Interview will be conducted on 25 Mar 2021 at 1100 hrs at Station Headquarters Devlali.

Candidates will bring original certificates/degree, photocopy of testimonials and experience certificates as applicable at the time of interview.

Only those individuals will be called for interview who fulfill all the requisite criteria

Related Posts

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

CHENNAI: The Madras High Court on Friday dismissed a petition seeking to quash a First Information Report (FIR) registered against Puducherry-based pharmaceutical entities accused of manufacturing and distributing counterfeit medicines…

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

Pharma companies in a flux over Trump’s 200% tariff move on generics

Pharma companies in a flux over Trump’s 200% tariff move on generics

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’